Peptone executive team will attend the JP Morgan Healthcare Investment Conference 2024 in San Francisco
We are excited to share that Dr. Kamil Tamiola, Dr. Patrik Foerch, and Dr. Ben Owens, who are key members of our executive team, will attend the annual JP Morgan Healthcare Investment Conference in San Francisco in 2024. During the conference, our team will provide updates on the rollout of our innovative HDX-MS technology for both small and large-molecule drug discovery, which is specifically designed for intrinsically disordered proteins (IDPs).
“We are looking forward to reconnecting with our investors, Pharma collaborators and peer biotechnology companies”, – said Dr. Kamil Tamiola, Chief Executive Officer.
Peptone is a translational biophysics company focused on the discovery of novel therapeutics against diseases driven by intrinsically disordered proteins. IDPs are proteins without a fixed structure that play a significant role in health and disease.